Hip
Senior Member (Voting Rights)
Don't forget that Simon Wessely was appointed to the board of Trustees of the SMC.
I think "last stand" may be nearer the mark.I am not sure I like that definition of a rearguard action. It can also be an action by small forces to delay an attack to enable the bulk of the forces to get away and fight another day on their own terms.
And I think it probably signifies some panic amongst the BSP crowdAn attempted pushback due to all the success we've been having recently, I would say, possibly even some attempted revenge for being ousted from the CMRC. One useful aspect of this is that it makes it even clearer how biased the SMC is, and to which side.
Well it's not exactly factual for one thing.This factsheet looks pretty desperate to me.
Well it's not exactly factual for one thing.
The blatant bias is so revealing! In a news media outlet! I really hope the SMC get their comeuppance in due course.Here's an explanation for that, and a new one
Those who disagree with this body of evidence cite review articles and reanalyses of trial data published in low impact factor journals such as The Journal of Health Psychology and Fatigue: Biomedicine, Health & Behavior
This factsheet looks pretty desperate to me.
“Medical care also has a role in helping patients to manage other symptoms such as pain”
Just wanted to say that rejection of PACE is not a guarantee of complete rejection of GET/CBT for ME/CFS.
Healthwise, which provides medical content for millions of Americans, has rejected PACE. However, Healthwise still points to Cochrane, unnamed clinical experts, and the assertion that GET/CBT remains beneficial for some patients to continue recommending GET/CBT. To be fair, Healthwise has deemphasized GET/CBT. But not abandoned the treatments.
Googling has shown me Healthwise has a number of psychosomatic medicine specialists on staff as content reviewers. Which could account for their reluctance to completely drop GET/CBT, even after abandoning PACE as unreliable.
I don't want to take this thread off track, but even if the Science Media Centre does abandon PACE, it doesn't necessarily mean they will completely abandon GET/CBT. Healthwise has shown there is a fallback position.
Well i assume the 'trial design specialists' would include Wessely & his co author, they wrote a book on 'clinical trials in psychiatry or something. Although whenever I've seen him talk about that book he always says "i wrote a book" rather than that he co authored it. Clearly considers himself an expert on trial design. Just cos you wrote a book doesn't mean that what your wrote stands up to science. Gwyneth Paltrow has written several I believe.I would love to know who these independent statisticians and trial design specialists actually are.
my bold.Maybe its a misprint by the SMC and its supposed to be a fuckedsheet, as in, "we are fucked".
No takers yet!
I think that's true, but as far as the newspapers etc go, we need to counter with a better story, and that isn't the math/science because the average reader response would be to glaze over.The strength of the PACE crew's strategy is that they tell a simple narrative which is easy for media to regurgitate – GET and CBT are effective, patients reject psych, some patients are meanies.
Re the 'low impact journal' bit, I'm sure i read an article not long ago about journal prestige not being linked to research quality. but i cant find it. Cant anyone else recall it?
This one is old & i cant read the full article w/out a subscription, but the recent article was along the same lines http://www.bmj.com/content/314/7079/497.1.full
Just thought if we could find that article, i sure it was published somehwere credible, someone could tweet it as part of the response to the 'fibsheet'.
ETA this one might also be an answer for that particular 'it wasnt in a prestigious journal therefore not worth listening to' nonsense... do you think it's any good @Jonathan Edwards? https://www.nature.com/news/beat-it...te-turns-against-controversial-metric-1.20224
Were you thinking of the one in this thread?Re the 'low impact journal' bit, I'm sure i read an article not long ago about journal prestige not being linked to research quality. but i cant find it. Cant anyone else recall it?